Haemostasiologic effects of various glucose-lowering medications in type 2 diabetes mellitus.

被引：0

作者：

Petrik, G. G. ^{[1
]}

Pavlishchuk, S. A. ^{[1
]}

机构：

[1] Kuban State Med Univ, Krasnodar, Russia

来源：

CARDIOVASCULAR THERAPY AND PREVENTION | 2010年 / 9卷 / 02期

关键词：

INSULIN;

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：48 / 53

页数：6

共 50 条

[31] The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes [J].

Pauline A. J. Vissers ;

Chris R. Cardwell ;

Lonneke V. van de Poll-Franse ;

Ian S. Young ;

Frans Pouwer ;

Liam J. Murray .

Breast Cancer Research and Treatment, 2015, 150 :427-437

[32] Insulin Monotherapy Versus Insulin Combined with Other Glucose-Lowering Agents in Type 2 Diabetes: A Narrative Review [J].

Abdi, Hengameh ;

Azizi, Fereidoun ;

Amouzegar, Atieh .

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 16 (02)

[33] The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes [J].

Vissers, Pauline A. J. ;

Cardwell, Chris R. ;

van de Poll-Franse, Lonneke V. ;

Young, Ian S. ;

Pouwer, Frans ;

Murray, Liam J. .

BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (02) :427-437

[34] Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: A perspective on glucose-lowering interventions [J].

Roussel, Ronan ;

Steg, Philippe Gabriel ;

Mohammedi, Kamel ;

Marre, Michel ;

Potier, Louis .

DIABETES OBESITY & METABOLISM, 2018, 20 (02) :238-244

[35] The Use of Colesevelam HCl in Patients with Type 2 Diabetes Mellitus: Combining Glucose- and Lipid-Lowering Effects [J].

Goldfine, Allison B. ;

Fonseca, Vivian A. .

POSTGRADUATE MEDICINE, 2009, 121 (03) :13-18

[36] Glucose-Lowering Medications, Glycemia, and Cognitive Outcomes The GRADE Randomized Clinical Trial [J].

Luchsinger, Jose A. ;

Rosin, Samuel P. ;

Kazemi, Erin J. ;

Younes, Naji ;

Suratt, Colleen E. ;

Fattaleh, Basma N. ;

Florez, Hermes J. ;

Gonzalez, Jeffrey S. ;

Hollander, Priscilla ;

Hox, Sophia H. ;

Kuo, Shihchen ;

Lee, Melissa S. ;

Martens, Thomas ;

Pop-Busui, Rodica ;

Seaquist, Elizabeth R. ;

Waltje, Andrea H. ;

Barzilay, Joshua I. .

JAMA INTERNAL MEDICINE, 2025, :778-787

[37] The relationship between glycated haemoglobin and blood glucose-lowering treatment trajectories in type 2 diabetes: The Fremantle Diabetes Study Phase II [J].

Davis, Timothy M. E. ;

Davis, Wendy .

DIABETES OBESITY & METABOLISM, 2024, 26 (01) :283-292

[38] Creative use of novel glucose-lowering drugs for type 2 diabetes: where will we head in the next 50 years? [J].

Ahren, Bo .

DIABETOLOGIA, 2015, 58 (08) :1740-1744

[39] Real world evidence of clinical predictors of glycaemic response to glucose-lowering drugs among Chinese with type 2 diabetes [J].

Wu, Hongjiang ;

Lau, Eric S. H. ;

Yang, Aimin ;

Fan, Baoqi ;

Ma, Ronald C. W. ;

Kong, Alice P. S. ;

Chow, Elaine ;

So, Wing-Yee ;

Chan, Juliana C. N. ;

Luk, Andrea O. Y. .

DIABETES-METABOLISM RESEARCH AND REVIEWS, 2023, 39 (04)

[40] Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER study [J].

Ji, Linong ;

Bonnet, Fabrice ;

Chen, Hungta ;

Cooper, Andrew ;

Hammar, Niklas ;

Leigh, Paul ;

Saraiva, Gabriela Luporini ;

Ramirez, Larisa ;

Medina, Jesus ;

Nicolucci, Antonio ;

Rathmann, Wolfgang ;

Shestakova, Marina, V ;

Surmont, Filip ;

Tang, Fengming ;

Watada, Hirotaka .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 178

← 1 2 3 4 5 →